DRRX - デュレクト （DURECT Corporation）

Durect (DRRX) is scheduled to announce Q4 earnings results on Tuesday, March 7th, after market close.The consensus EPS Estimate is -$0.55 (-1733.3% Y/Y) and the consensus Revenue…

Durect (NASDAQ: DRRX ) is set to give its latest quarterly earnings report on Tuesday, 2023-03-07. Here''s what investors need to know before the announcement. Analysts estimate that Durect will report an earnings per share (EPS) of $-0.55. Durect bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com

CUPERTINO, Calif., Feb. 28, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and full year 2022 financial results and host a conference call after the market close on Tuesday, March 7, 2023. Tuesday, March 7 @ 4:30pm Eastern…

As an investor, you can get some amazing deals in the stock market. You can even fund some great stocks under $10 to buy if you know where to look. What’s the attraction to buying a stock under $10? Well, not everyone likes to spend $100 or more on a large-cap stock that carries a big price tag. Buying a stock under $10 means that for that same $100 you can pick up 10 shares instead of just one. Generally, stocks under $10 to buy are more likely to be growth stocks with longer runways to provide investors with some great returns. If you need help identifying stocks under $10 to buy, then I’ve got you covered. My Portfolio Grader tool evaluates and ranks stocks on an A through F scale based on a variety of metrics including earnings, recent performance, analyst sentiment and momentum. If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI BigBear.ai $4.05 APPH AppHarvest $0.95 DRRX Durect 5.18 AUVI Applied UV $1.13 ARDX Ardelyx $3.04 LIZI Lizhi $1.01 RIG Transocean $7.57 BigBear.ai (BBAI) Source: whiteMocca / Shutterstock BigBear.ai (NASDAQ: BBAI ) may have an unusual name, but it’s one of the hottest stocks on Wall Street and one of the best stocks under $10 to buy.

Source: ventdusud / Shutterstock.com We’re starting off the week with an overview of the biggest pre-market stock movers for Monday! Moving stocks this morning are funding updates, earnings, and stock offerings. Let’s get into that news below! Pre-Market Stock Movers: 10 Top Gainers Secoo Holding (NASDAQ: SECO ) stock is rocketing more than 77% alongside heavy pre-market trading. Jiuzi Holdings (NASDAQ: JZXN ) shares are soaring over 45% as it also sees strong early morning trading on Monday. Kalera PLC (NASDAQ: KAL ) stock is surging more than 42%, which builds on Friday’s gains. Faraday Future (NASDAQ: FFIE ) shares are climbing over 34% after obtaining funding for electric vehicle (EV) production. Elys Game Technology (NASDAQ: ELYS ) stock is gaining more than 28% following an update on debentures and warrants . Catalent (NYSE: CTLT ) shares are increasing over 28% on reports Danaher (NYSE: DHR ) may want to acquire the company . T Stamp (NASDAQ: IDAI ) stock is heading more than 28% higher this morning.

https://www.investing.com/news/pro/durect-corp-pt-raised-to-35-at-hc-wainwright-432SI-2958185

DURECT Corporation (NASDAQ:DRRX)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 1.23. At the close of trading, the stock’s price was $0.40, to imply a decrease of -2.61% or -$0.01 in intraday trading. The DRRX share’s 52-week high remains $1.09, putting it -172.5% down since that peak … Should You Expect A Quick Recovery From DURECT Corporation (NASDAQ: DRRX) After -172.5% Decline From High? Read More »

CUPERTINO, Calif. , Nov. 28, 2022 /PRNewswire/ -- DURECT Corporation (NASDAQ: DRRX ), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver diseases, announced that DURECT''s board of directors today determined that the Company will effect a reverse stock split at a ratio of 1-for-10 as of 5:01 p.m. Eastern Time on December 5, 2022 . Beginning with the opening of trading on December 6, 2022 , the Company''s common stock will trade on a split-adjusted basis. At a Special Meeting of Stockholders held on November 22, 2022 , DURECT stockholders voted to approve a proposal authorizing the board of directors of the Company to amend the Company''s certificate of incorporation to effect a reverse stock split of DURECT''s outstanding common shares at an exchange ratio of not less than 1-for-10 and not greater than 1-for-20, and a reduction in the number of authorized shares of common stock from 600,000,000 to 150,000,000 shares.

DURECT Corporation (NASDAQ:NASDAQ:DRRX) Q3 2022 Earnings Conference Call November 02, 2022, 04:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive…

Durect press release (DRRX): Q3 GAAP EPS of -$0.01 in-line.Revenue of $11.98M (vs

Charles Schwab Investment Management Inc. increased its stake in shares of DURECT Co. (NASDAQ:DRRX) by 4.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 573,991 shares of the specialty pharmaceutical companys stock after purchasing an additional 26,288 shares during the period. Charles []

California State Teachers Retirement System cut its position in DURECT Co. (NASDAQ:DRRX) by 7.1% during the 2nd quarter, HoldingsChannel reports. The firm owned 312,482 shares of the specialty pharmaceutical companys stock after selling 23,890 shares during the quarter. California State Teachers Retirement Systems holdings in DURECT were worth $509,000 as of its most recent filing []

Nuveen Asset Management LLC cut its stake in shares of DURECT Co. (NASDAQ:DRRX) by 6.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 932,510 shares of the specialty pharmaceutical companys stock after selling 64,997 shares during the quarter. Nuveen Asset Management LLC []

MetLife Investment Management LLC decreased its position in shares of DURECT Co. (NASDAQ:DRRX) by 74.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,530 shares of the specialty pharmaceutical companys stock after selling 69,869 shares during the period. MetLife Investment Management []

DURECT Corporation (NASDAQ:DRRX) price on Thursday, November 18, rose 1.80% above its previous days close as an upside momentum from buyers pushed the stocks value to $1.13. A look at the stocks price movement, the close in the last trading session was $1.11, moving within a range at $1.10 and $1.19. The beta value (5-Year Data-Based Insights About DURECT Corporation (DRRX) Read More »